• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人中慢性阻塞性肺疾病与心力衰竭并存

Coexistent chronic obstructive pulmonary disease and heart failure in the elderly.

作者信息

Padeletti Margherita, Jelic Sanja, LeJemtel Thierry H

机构信息

Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY, United States.

出版信息

Int J Cardiol. 2008 Apr 10;125(2):209-15. doi: 10.1016/j.ijcard.2007.12.001. Epub 2008 Jan 24.

DOI:10.1016/j.ijcard.2007.12.001
PMID:18221802
Abstract

The prevalence of chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) increases substantially with age. The coexistence of COPD and CHF is common but often unrecognized in elderly patients. To avoid overlooking COPD in elderly patients with known CHF pulmonary function tests should be routinely obtained. Likewise, to avoid overlooking CHF in elderly patients with known COPD left ventricular (LV) function should be routinely assessed. Plasma brain natriuretic peptide levels are useful to differentiate COPD exacerbation from CHF decompensation in patients presenting with acute dyspnea. Aging exacerbates skeletal muscle alterations that occur in patients with CHF and COPD. Skeletal muscle metabolic alterations and atrophy and the resulting deterioration of functional capacity progress rapidly in elderly patients with COPD and CHF. Physical conditioning reverses rapidly progressing skeletal muscle metabolic alterations and atrophy and promotes independence and life quality in the elderly. Physical conditioning is clearly an essential component of the management of elderly patients with COPD and CHF. The pharmacological management of patients with coexistent COPD and CHF should focus on not depriving these patients from long-term beta adrenergic blockade. Long-term beta adrenergic blockade has been repeatedly shown to improve survival in elderly patients with CHF due to LV systolic dysfunction and, contrary to conventional belief, is well tolerated by patients with COPD.

摘要

慢性阻塞性肺疾病(COPD)和慢性心力衰竭(CHF)的患病率随年龄大幅增加。COPD和CHF并存很常见,但在老年患者中往往未被认识到。为避免在已知患有CHF的老年患者中漏诊COPD,应常规进行肺功能检查。同样,为避免在已知患有COPD的老年患者中漏诊CHF,应常规评估左心室(LV)功能。血浆脑钠肽水平有助于鉴别急性呼吸困难患者的COPD加重与CHF失代偿。衰老会加剧CHF和COPD患者出现的骨骼肌改变。在患有COPD和CHF的老年患者中,骨骼肌代谢改变、萎缩以及由此导致的功能能力下降进展迅速。体能锻炼可逆转迅速进展的骨骼肌代谢改变和萎缩,并促进老年人的独立性和生活质量。体能锻炼显然是老年COPD和CHF患者管理的重要组成部分。COPD和CHF并存患者的药物治疗应注重不剥夺这些患者长期使用β肾上腺素能阻滞剂的机会。长期β肾上腺素能阻滞剂已多次被证明可提高因LV收缩功能障碍导致CHF的老年患者的生存率,而且与传统观念相反,COPD患者对其耐受性良好。

相似文献

1
Coexistent chronic obstructive pulmonary disease and heart failure in the elderly.老年人中慢性阻塞性肺疾病与心力衰竭并存
Int J Cardiol. 2008 Apr 10;125(2):209-15. doi: 10.1016/j.ijcard.2007.12.001. Epub 2008 Jan 24.
2
Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.慢性阻塞性肺疾病和慢性心力衰竭并存患者的诊断和治疗挑战
J Am Coll Cardiol. 2007 Jan 16;49(2):171-80. doi: 10.1016/j.jacc.2006.08.046. Epub 2006 Dec 29.
3
Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease.心血管磁共振成像用于识别稳定期慢性阻塞性肺疾病患者的左侧慢性心力衰竭。
Am Heart J. 2008 Sep;156(3):506-12. doi: 10.1016/j.ahj.2008.04.021. Epub 2008 Jun 17.
4
Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.治疗进展:慢性阻塞性肺疾病和慢性心力衰竭并存患者的非选择性β和α肾上腺素能阻滞剂治疗
J Am Coll Cardiol. 2004 Aug 4;44(3):497-502. doi: 10.1016/j.jacc.2004.03.063.
5
Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.呼吸困难及临床变量对慢性阻塞性肺疾病和充血性心力衰竭患者生活质量及功能能力的影响。
Chin Med J (Engl). 2008 Apr 5;121(7):592-6.
6
Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure.慢性阻塞性肺疾病患者与充血性心力衰竭患者对呼吸困难的描述。
Heart Lung. 2004 Mar-Apr;33(2):102-10. doi: 10.1016/j.hrtlng.2003.11.004.
7
Developing the model of pulmonary rehabilitation for chronic heart failure.开发慢性心力衰竭肺康复模型。
Chron Respir Dis. 2011;8(4):259-69. doi: 10.1177/1479972311423111.
8
Unrecognised ventricular dysfunction in COPD.COPD 中的未识别心室功能障碍。
Eur Respir J. 2012 Jan;39(1):51-8. doi: 10.1183/09031936.00044411. Epub 2011 Jun 23.
9
Coexistent chronic obstructive pulmonary disease-heart failure: mechanisms, diagnostic and therapeutic dilemmas.慢性阻塞性肺疾病合并心力衰竭:机制、诊断及治疗困境
Indian J Chest Dis Allied Sci. 2010 Oct-Dec;52(4):225-38.
10
Aging and heart failure--similar syndromes of exercise intolerance? Implications for exercise-based interventions.衰老与心力衰竭——运动不耐受的相似综合征?对基于运动的干预措施的启示。
Heart Fail Monit. 2005;4(4):130-6.

引用本文的文献

1
A 7-point evidence-based care discharge protocol for patients hospitalized for exacerbation of COPD: consensus strategy and expert recommendation.慢性阻塞性肺疾病急性加重住院患者基于证据的7点出院护理方案:共识策略与专家建议
NPJ Prim Care Respir Med. 2024 Dec 20;34(1):44. doi: 10.1038/s41533-024-00378-7.
2
Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary.烟草与 COPD:介绍世界卫生组织(WHO)烟草知识摘要。
Respir Res. 2024 Sep 11;25(1):338. doi: 10.1186/s12931-024-02961-5.
3
The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics.
慢性阻塞性肺疾病(COPD)的分子蓝图:诊断和治疗的新模式。
Oxid Med Cell Longev. 2023 Dec 21;2023:2297559. doi: 10.1155/2023/2297559. eCollection 2023.
4
Managing patients with comorbidities: future models of care.管理患有合并症的患者:未来的护理模式。
Future Healthc J. 2022 Jul;9(2):101-105. doi: 10.7861/fhj.2022-0029.
5
Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后早期再入院的危险因素。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620961688. doi: 10.1177/1753466620961688.
6
Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door.心力衰竭中的非心脏合并症聚集:一个被忽视的具有潜在治疗意义的方面。
Heart Fail Rev. 2022 May;27(3):767-778. doi: 10.1007/s10741-020-09972-6.
7
Mortality in Advanced Chronic Obstructive Pulmonary Disease and Heart Failure Following Cardiopulmonary Rehabilitation.心肺康复后晚期慢性阻塞性肺疾病和心力衰竭患者的死亡率
Biol Res Nurs. 2018 Jul;20(4):429-439. doi: 10.1177/1099800418772346. Epub 2018 Apr 29.
8
Disparate Rates of Utilization and Progression to Combined Heart Failure and Chronic Obstructive Pulmonary Disease among Asians and Pacific Islanders in Hawai'i.夏威夷亚裔和太平洋岛民中心力衰竭合并慢性阻塞性肺疾病的不同利用率和进展率
Hawaii J Med Public Health. 2016 Aug;75(8):228-34.
9
Clinical factors associated with early readmission among acutely decompensated heart failure patients.急性失代偿性心力衰竭患者早期再入院的相关临床因素。
Arch Med Sci. 2016 Jun 1;12(3):538-45. doi: 10.5114/aoms.2016.59927. Epub 2016 May 18.
10
COPD Readmissions: Addressing COPD in the Era of Value-based Health Care.慢性阻塞性肺疾病再入院:在基于价值的医疗保健时代应对慢性阻塞性肺疾病
Chest. 2016 Oct;150(4):916-926. doi: 10.1016/j.chest.2016.05.002. Epub 2016 May 7.